Literature DB >> 8589138

High rate of transmission of tuberculosis in an office: impact of delayed diagnosis.

C R MacIntyre1, A J Plant, J Hulls, J A Streeton, N M Graham, G J Rouch.   

Abstract

We identified two cases of tuberculosis (TB) in office co-workers in Melbourne, Victoria, Australia; the Mycobacterium tuberculosis isolates were found to be identical with use of restriction fragment length polymorphism. Contact tracing was performed for 195 of 210 workers by means of the tuberculin skin test. Risk of infection was assessed according to a number of variables. Office contacts were exposed to infectious TB for 4 months; at least 24% of employees were infected. There was an association between sitting in proximity to the case during the period of exposure (OR, 4.24; 95% CI, 1.06-19.67). On-site workers had a higher risk of being infected (OR, 5.48; CI, 1.51-23.54) than did visiting workers. Workers in this office were exposed to open pulmonary TB for prolonged periods. The prevalence of TB infection (24%) among these workers was high compared with the infection rate (2%-7%) in the general community. Delay in diagnosis was the major factor responsible for the spread of TB in this office.

Entities:  

Mesh:

Year:  1995        PMID: 8589138     DOI: 10.1093/clinids/21.5.1170

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  New developments in BCG vaccine: implications for tuberculosis control.

Authors:  C R MacIntyre
Journal:  Epidemiol Infect       Date:  2007-02       Impact factor: 2.451

2.  Field evaluation of a rapid immunochromatographic test for tuberculosis.

Authors:  Celine Gounder; Fernanda Carvalho De Queiroz Mello; Marcus B Conde; William R Bishai; Afrânio L Kritski; Richard E Chaisson; Susan E Dorman
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Identification of Mycobacterium tuberculosis antigens of high serodiagnostic value.

Authors:  Gregory C Ireton; Rena Greenwald; Hong Liang; Javan Esfandiari; Konstantin P Lyashchenko; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2010-08-18

4.  Comparison of C(18)-carboxypropylbetaine and standard N-acetyl-L-cysteine-NaOH processing of respiratory specimens for increasing tuberculosis smear sensitivity in Brazil.

Authors:  Cherise P Scott; Luciano Dos Anjos Filho; Fernanda Carvalho De Queiroz Mello; Charles G Thornton; William R Bishai; Leila S Fonseca; AfrAnio L Kritski; Richard E Chaisson; Yukari C Manabe
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  Preventable mix-ups of tuberculin and vaccines: reports to the US Vaccine and Drug Safety Reporting Systems.

Authors:  Soju Chang; Vitali Pool; Kathryn O'Connell; Jacquelyn A Polder; John Iskander; Colleen Sweeney; Robert Ball; M Miles Braun
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Whole genome sequencing for improved understanding of Mycobacterium tuberculosis transmission in a remote circumpolar region.

Authors:  J L Guthrie; L Strudwick; B Roberts; M Allen; J McFadzen; D Roth; D Jorgensen; M Rodrigues; P Tang; B Hanley; J Johnston; V J Cook; J L Gardy
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

7.  Incidence, duration and risk factors associated with delayed and missed diagnostic opportunities related to tuberculosis: a population-based longitudinal study.

Authors:  Aaron C Miller; Alan T Arakkal; Scott Koeneman; Joeseph E Cavanaugh; Alicia K Gerke; Douglas B Hornick; Philip M Polgreen
Journal:  BMJ Open       Date:  2021-02-18       Impact factor: 3.006

8.  Tuberculosis and Migration: A Challenge for Medical Staff and Public Health.

Authors:  Ines Griesshammer; David Shiva Srivastava; Christophe von Garnier; Till Silvan Blaser; Aris Exadaktylos; Moritz Steib
Journal:  Case Rep Emerg Med       Date:  2016-11-14

9.  An office building outbreak: the changing epidemiology of tuberculosis in Shenzhen, China.

Authors:  X J Guo; H E Takiff; J Wang; G Y Han; Y Z Fan; G H Wu; J P Ma; S Y Liu
Journal:  Epidemiol Infect       Date:  2020-02-24       Impact factor: 2.451

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.